Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapyGilles Crehange, Devan Krishnamurthy, J Adam Cunha, et al.Brachytherapy|July 23, 2015
Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancerDavid R Raleigh, Albert J Chang, Bryan Tomlin, et al.American Journal of Orthopedics (Belle Mead, N.J.)|July 2, 2011
Patellar metastatic melanoma in a 13-year-old boyThomas F Burk, Andrew E Horvai, Alexander R Gottschalk, et al.Advances in Radiation Oncology|July 18, 2022
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 TrialKevin Shee, Claire M de la Calle, Albert J Chang, et al.International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA responseSiavash Jabbari, Vivian K Weinberg, Tania Kaprealian, et al.Journal of Applied Clinical Medical Physics|April 28, 2018
Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapyChristopher H Chapman, Christopher McGuinness, Alexander R Gottschalk, et al.Sarcoma|October 17, 2006
Clinical outcomes of intraoperative radiation therapy for extremity sarcomasQuy N H Tran, Anne C Kim, Alexander R Gottschalk, et al.Journal of Applied Clinical Medical Physics|September 17, 2013
Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnifeMartina Descovich, Mauro Carrara, Sara Morlino, et al.Journal of Contemporary Brachytherapy|July 25, 2018
Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapyChristopher H Chapman, Steve E Braunstein, Jean Pouliot, et al.International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boostSiavash Jabbari, Vivian K Weinberg, Katsuto Shinohara, et al.Pageof 6